3 Undervalued Media Stocks for Wednesday, November 13
Discover the top 3 undervalued Media stocks for Wednesday, November 13 based on AAII’s Stock Grades.Tudor Pop
Stock Evaluator: Haoxi Health Technology Limited (HAO)
Haoxi Health Technology Limited HAO
$1.95
-0.19
-8.88%
October 21, 2026 4:00:00 PM
EST
Volume: 19,259
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Communication Services | Media |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. The company offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. It places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Weibo. It serves advertiser client base primarily in the healthcare industry. Haoxi Health Technology Limited was founded in 2018 and is based in Chaoyang, China.
Commentary & Analysis
Financial Summary
| Share Statistics | HAO | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1.4 | $414.6 | 1% |
|
| Shares Out (Mil) | 0.0 | 37.3 | 0% |
|
| Institutional Ownership | 15.8% | 50.0% | 8% |
|
| Float (Mil) | 0.6 | 37.7 | 1% |
|
| Beta | -1.08 | 0.91 | 1% |
|
| Avg Daily Volume (000s) | 32 | 198 | 25% |
|
| Price Change (52-week) |
(99.9%) | 59.6% | 0% |
|
| Growth | HAO | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 33.8% | 2.6% | 91% |
|
| Net Income (5yr) | (102.0%) | (5.3%) | 2% |
|
| EPS (5yr) | na | 1.8% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (16.3%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | HAO | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $55 | $599 | 21% |
|
| Net Income (TTM) (Mil) | ($10) | ($3) | 30% |
|
| EPS (TTM) | ($386.396) | ($0.100) | 0% |
|
| Operating Cash Flow (TTM) (Mil) | ($3) | $53 | 28% |
|
| Net Cash Flow (TTM) (Mil) | $2 | ($2) | 49% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $149 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($8) | $714 | 2% |
|
| Valuation | HAO | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.01 | 1.15 | 0% |
|
| P/E | na | 21.9 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 0.7 | na |
|
| Ratios | HAO | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 1.1% | 42.5% | 5% |
|
| Net Margin | (17.4%) | (1.8%) | 17% |
|
| ROA | (44.2%) | (1.4%) | 13% |
|
| ROE | (54.1%) | (1.2%) | 15% |
|
| Liabilities to Assets | 17.2% | 59.5% | 11% |
|
| F-Score | 3 | 4 | na |
|
Haoxi Health Technology Limited did not pass any screens on 10/20/2026.
